WinstonWınston
Fuse Science logo

Fuse Science

DROP
13
Software - Application · Technology
Price
$0.01
+0.00 (+6.48%)
Market Cap
$920,000
Exchange
Other OTC
Winston Score
13
Winston is worried
Weak fundamentals across most pillars.
Based on the IPO prospectus (annual filing). This score will refine automatically once the company reports its first quarters.
Data as of Aug 9, 2026 · filings through Dec 31, 2025

Share count rising — dilution

+212.5% over 10y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 80.0M (2015) → 250.0M (2025)

Fuse Science, Inc. is a small company that has operated in the consumer products and technology space, originally focused on delivery technology for supplements and energy products. The company developed a system to dissolve nutrients and active ingredients directly into the mouth, bypassing the need for traditional pills or drinks. It has targeted athletes and everyday consumers looking for faster-absorbing nutritional supplements.

Fuse Science generates revenue through product sales and has explored licensing its delivery technology to other brands. The company is based in the United States and has an extremely small market presence, with essentially no meaningful revenue or profitability reflected in its current financials. The biggest risk facing Fuse Science is its lack of demonstrated commercial traction — with zero reported gross margin and operating margin, the company faces serious questions about whether it can build a sustainable business model at all.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

YoY Growth Rate

EPS data limited

R&D Spend

$0/ year

0.0% of revenue

Below sector average (15%)

Research and development spending

Insider Activity

7.4%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$40,228 cash & investments

Quarterly Free Cash Flow

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Fuse Science's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
0.0%
Thin — 0.0% gross margin
Operating Margin
-161.3%
Losing money on operations — -161.3%
ROCE
-41.4%
Weak — -41.4% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-84.0%
Shrinking sales (-84.0% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
61.4%
Converts sales into free cash efficiently (61.4%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.00
Conservative — low debt load (0.00)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial